GSK plc GSK
NYSE GSK
$48.68 -0.08 (-0.16%)
At close: Oct 29, 2026 · 4:00 PM EDT

Gsk (GSK) Non-cash Items (2011 - 2013)

Updated

Gsk's Non-cash Items came in at $3.5 billion for the year ended Dec 31, 2025, down 44.2% from $6.28 billion a year earlier.

Analysis

Gsk (GSK) Non-cash Items (2011 - 2013) Analysis & Trends

Going back to the year ended Dec 31, 2009, Gsk's Non-cash Items data covers 17 years.

  • Non-cash Items carries a five-year compound annual growth rate of 1.2% (years ended Dec 2020 to Dec 2025).
  • The five-year range for annual Non-cash Items is -$5.14 billion (the year ended Dec 31, 2021) to $6.28 billion (the year ended Dec 31, 2024).
  • Per Business Quant, earlier years put Non-cash Items at $6.28 billion in the year ended Dec 31, 2024 (+81.0%), $3.47 billion in the year ended Dec 31, 2023 (-7.3%), $3.74 billion in the year ended Dec 31, 2022 and -$5.14 billion in the year ended Dec 31, 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,264.17 Bn 1,237.79 Bn 20.46 Bn
2 Johnson & Johnson 660.04 Bn 579.90 Bn 17.30 Bn
3 AbbVie 521.06 Bn 494.17 Bn 12.70 Bn
4 Merck 370.60 Bn 370.60 Bn -
5 Novartis Ag 311.97 Bn 285.20 Bn -
6 Astrazeneca 288.69 Bn 262.37 Bn 12.86 Bn
7 Amgen 252.29 Bn 207.69 Bn 7.24 Bn
8 Gilead Sciences 213.47 Bn 213.47 Bn -
9 Pfizer 173.68 Bn 120.32 Bn 10.94 Bn
10 Gsk 100.27 Bn 83.11 Bn 8.73 Bn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2013 90.67 Mn
Dec 31, 2012 -107.59 Mn
Dec 31, 2011 141.44 Mn
API Access

Gsk Non-cash Items API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-cash-items&ticker=GSK&period=max&api_key=YOUR_API_KEY